Working together, Acerta and AstraZeneca are focused on Innovative Clinical Strategies to enable us to combine our extensive oncology portfolio of cancer therapies as well as combinations with exciting, novel compounds in development at partner companies. The Haematology projects in Clinical Development are shown in the global AZ pipeline.